The program will be packed with papers on biochromatography, downstream processing, QbD, monoclonal antibodies, plasmids, enzymes, vaccines, viral vectors for
gene delivery, VLPs, and other biopharmaceuticals, chiral molecules, SFC, fine chemicals, peptides, proteins, oligonucleotides, APIs, natural products, batch, multi-column and continuous SMB processes, column
technology and equipment, monoliths, new and improved stationary phases, membrane chromatography, regulatory aspects, and more!
The title of the paper is «The Ideal
Gene Delivery Vector: Chromallocytes, Cell Repair Nanorobots for Chromosome Replacement Therapy» and it is currently in press at the peer - reviewed Journal of Evolution and
Technology (and is soon to be available online).
This molecule brings a revolutionary
technology platform for genetic engineering in vertebrates, including
gene discovery in model species and for therapeutic transgene
delivery for possible human applications.
Important reports from the Weiner lab include the first DNA vaccine studied for HIV as well as for cancer immune therapy of cutaneous T cell lymphoma, the early development of DNA encoded genetic adjuvants, including IL - 12, advances in
gene optimization, and advances in electroporation
technologies resulting in improved
gene delivery.